Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)

Clinical trial NCT00758069 · COMPLETED

Trial details

NCT number: NCT00758069
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus, Non-Insulin-Dependent

Start date: 2005-07-03
Primary completion: 2006-02-13
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.